NCT00002644View on ClinicalTrials.gov

Tamoxifen for the Prevention of Breast Cancer in High-Risk Women

PHASE3CompletedINTERVENTIONAL
Enrollment

7,154

Participants

Timeline

Start Date

January 31, 1994

Primary Completion Date

January 31, 2001

Study Completion Date

March 30, 2011

Conditions
Breast Cancer
Interventions
DRUG

Tamoxifen Citrate 20Mg Tab

Tamoxifen Citrate 20Mg Tab

OTHER

Placebo

Placebo 20Mg Tab

Trial Locations (1)

EC1M6BQ

Queen Mary University of London, London

All Listed Sponsors
lead

Queen Mary University of London

OTHER